Clinical Trial Update: A Phase 2 Clinical Study of KHK4827 [Phase 2]

View source ↗

Summary

Update on a Phase 2 study of KHK4827 for moderate to severe plaque psoriasis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• KHK4827

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Moderate to Severe Plaque Psoriasis | Phase 2 | Status: COMPLETED